Chongqing Changsheng Shenghe Pharmaceutical Private Equity Investment Fund Partnership Enterprise and China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) agreed to acquire 18.7751% stake in Runsheng Pharmaceutical Co., Ltd. from Chongqing Boyi Xintian Equity Investment Fund Partnership Enterprise (Limited Partnership) managed by Tasly Capital and Chongqing Juxin Investment Co., Ltd. for CNY 58.9 million on January 4, 2024. The consideration consists of CNY 58.91 million in cash. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. board of directors approved the transaction.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Equities
000999
CNE0000011K8
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
61.12 CNY | +0.39% | +1.92% | +22.90% |
19/04 | China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
25/03 | CR Sanjiu's 2023 Profit Climbs 16.5%, Revenue Jumps 37% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.90% | 8.36B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
-2.71% | 159B |
- Stock Market
- Equities
- 000999 Stock
- News China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
- Chongqing Changsheng Shenghe Pharmaceutical Private Equity Investment Fund Partnership Enterprise and China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. agreed to acquire 18.7751% stake in Runsheng Pharmaceutical Co., Ltd. from Chongqing Boyi Xintian Equity Investment Fund Partnership Enterprise (Limited Partnership), Tasly Capital and Chongqing Juxin Investment Co., Ltd. for CNY 58.9 million .